MedTrace Logo

The Villainous Vape: Advancing Vaping Prevention Among Adolescents Through a Comic Book

NCT07737080 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-07-30

No results posted yet for this study

Summary

This is a randomized controlled trial to assess the feasibility, acceptability, and preliminary impact of The Villainous Vape, a vaping prevention comic book, among adolescents.

Conditions

  • Vaping Behaviors

Interventions

BEHAVIORAL

Health Impacts of E-cigarettes

Health Impacts of E-cigarettes is a one-page educational flyer that outlines the impact of using electronic cigarettes and what is being done to mitigate youth vaping. The flyer reviews the dangers of nicotine delivery devices, lung damage, and how to stay safe in the event of social exposure to vaping. Health Impacts of E-cigarettes was developed by the U.S. Food and Drug Administration.

BEHAVIORAL

Mind Matters: The Body's Response to Nicotine, Tobacco, and Vaping

Mind Matters: The Body's Response to Nicotine, Tobacco, and Vaping is a five-page educational brochure that utilizes an illustrative approach to sharing basic information about nicotine and tobacco products. The brochure focuses on the physiological effect of these products, health effects, addiction, and key statistics. Mind Matters: The Body's Response to Nicotine, Tobacco, and Vaping was developed by the U.S. National Institute on Drug Abuse.

BEHAVIORAL

The Villainous Vape

The Villainous Vape is an eleven-page comic book that follows Daniel, a high school student who gets addicted to vaping and is hospitalized in the intensive care unit because he develops a lung disease. Support from friends and family helps Daniel make the decision to quit vaping. Throughout the comic, readers are exposed to various vaping-related facts and statistics.

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07737080 on ClinicalTrials.gov